CAPLIN
GenericsCAPLIN is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Respiratory. Key products include POTASSIUM PHOSPHATES.
CAPLIN's Key Drugs
CAPLIN's core commercial portfolio centers on BRIMONIDINE TARTRATE AND TIMOLOL MALEATE, SODIUM PHOSPHATES, POTASSIUM PHOSPHATES, spanning Cardiovascular and Infectious Disease — its most strategically important drugs approved in the last 15 years.
CAPLIN's Recent FDA Approvals
CAPLIN secured 2 new FDA approvals for novel drugs (NDA/BLA) in the last two years.
CAPLIN's Therapeutic Areas
CAPLIN's approved drugs and pipeline span 5 therapeutic areas, led by Cardiovascular and Infectious Disease, across 0 biologic and 2 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
CAPLIN's Top Competitors
CAPLIN's closest competitors by therapeutic-area and drug-target overlap include Pfizer, GE HEALTHCARE, and Merck. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
CAPLIN Pipeline Snapshot
Active clinical trials for CAPLIN across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • BRIMONIDINE TARTRATE AND TIMOLOL MALEATE leads revenue
- • 3 key drugs tracked
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Discontinued (0)
Company Info
- First Approval
- 1985-01-16
- Latest
- 2026-05-13
- Applications
- 51